Successful brentuximab vedotin monotherapy against late relapse of classical Hodgkin lymphoma 6 years after first remission. [electronic resource]
Publication details: Clinical case reports Mar 2020Description: 466-468 p. digitalISSN:- 2050-0904
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.